The Deen's ListTM
A service of Deen Capital Management, Inc. (www.deencapital.com)
Vol.2 #319 Wednesday, December 29, 2004 3:58PM ET

Please read carefully our disclaimers at the end of this newsletter.

Market Stance: BULLISH (since December 15, 2004)

  Contents

Year-To-Date Performance
Bought Lam Research Corp. (LRCX)
Open Positions
Subscription Information
Privacy Policy
Disclaimers

  Year-To-Date Performance

Year-To-Date as of December 28, 2004

Deen Capital+4.3%*
S&P 500+9.1%

* An average of managed accounts, net after commissions and fees. Individual account results may vary. See also www.deencapital.com/perform.htm. For information on managed accounts, see www.deencapital.com/mgdaccts.htm.

  Bought Lam Research Corp. (LRCX)

Net buy price in managed accounts* $28.44
Most recent close (Dec 28) $27.73
Net change (based on net buy price) +$0.71
Today's volume as of 3:43pm ET 1.1 million ($30.3 million)
Average daily volume 2.5 million ($70.1 million)
This year's earnings-per-share $2.03 (est)
Next year's earnings-per-share $1.85 (est)
P/E using next year's earnings 15.4 (est)
Earnings growth rate, next 5 years 20.0% per year (est)
Web site http://www.lamrc.com

* The "Net buy price" is the total net purchase cost after commissions for all managed accounts divided by the total number of shares.

Today, Wednesday, December 29, 2004, I bought LRCX, first for client accounts, then for my personal accounts. Lam Research Corp. designs, manufactures, markets and services semiconductor processing equipment used in the fabrication of integrated circuits for the worldwide semiconductor industry.

Here's why I bought this stock:

+ End of dip? The stock has been trading generally lower since peaking at $29.40 on Dec 6. Since Dec 6, the stock has twice found support within a couple of pennies of $27.73. The second time is now. (Yesterday's close was $27.73, and today the stock is up modestly.) It is my guess that the mild downtrend since Dec 6 has just ended.

+ The stock's 200-day moving average has just recently turned around. Prior to November, it was falling; now it is rising. The stock, then, is in a long-term uptrend.

+ Excellent and dramatically accelerating recent sales growth: Here are the quarterly year-to-year sales growth rates from the last four quarters, in chronological order: +4%, +24%, +77%, and, most recently, for the quarter ended Sep 30, +128% to $419.5 million.

+ Excellent recent earnings-per-share growth: Here are the quarterly EPS figures for the last eight quarters:

Dec 03 vs Dec 02:  7c vs 2c
Mar 04 vs Mar 03: 14c vs 3c
Jun 04 vs Jun 03: 37c vs 2c
Sep 04 vs Sep 03: 64c vs 4c

+ Next year's earnings estimate is rising sharply: According to recent data from First Call, the consensus earnings estimate for FY 05 (Jun) is $2.03, down from $2.37 90 days ago (but up from FY 04 actual earnings of 62c); more importantly, in my view, the consensus estimate for next year, FY 06, has risen to $1.85 from $1.42 over the past 90 days ago.

+ Valuation: At 15 times next year's estimated earnings and a projected 5-year annualized earnings growth rate of 20%, the stock is very attractively priced.

+ History of earnings surprises: This company has reported earnings at least 2c ahead of estimates in each of the past four quarters, and 6c ahead in the most recently reported quarter, the one ended Sep 30.

+ The company's industry group ("Semiconductor Equipment") is ranked #157 for relative strength out of 197 industry groups tracked by Investor's Business Daily. This is low, but it has been generally rising over recent weeks and months.

I chose to buy the stock in spite of the following negative factor:

- Next year's earnings estimate is slightly less than this year's earnings estimate. (On the other hand, as stated above, the 5-year earnings growth rate is projected to be a very healthy 20% per year.)

-KD, December 29, 2004

  Open Positions

Company Name Stock
Symbol
Buy
Date
NetBuy
Price*
Current
Price**
Weeks
Held
Gain
(Loss)
Lam Research Corp.LRCX12/29/04$28.44$28.350.0-0.3%
AMX Corp.AMXC12/29/04$16.44$16.500.0+0.4%
Lifecore Biomedical Inc.LCBM12/28/04$11.45$11.150.1-2.6%
Korn/Ferry InternationalKFY12/28/04$21.01$20.940.1-0.3%
EZCORP, Inc.EZPW12/28/04$15.29$15.080.1-1.4%
Resources Connection, Inc.RECN12/23/04$52.09$55.300.9+6.2%
MPS Group, Inc.MPS12/23/04$12.28$12.260.9-0.2%
Garmin Ltd.GRMN12/23/04$59.98$61.470.9+2.5%
Insteel Industries Inc.IIIN12/22/04$19.29$19.981.0+3.6%
Nextel Partners Inc.NXTP12/21/04$19.08$19.581.1+2.6%
Infocrossing Inc.IFOX12/21/04$17.45$17.401.1-0.3%
Aleris International Inc.ARS12/20/04$14.69$16.651.3+13.4%
Armor Holdings Inc.AH12/17/04$46.40$47.701.7+2.8%
Sirenza MicrodevicesSMDI12/16/04$5.91$6.661.9+12.7%
Olympic Steel Inc.ZEUS12/15/04$23.95$29.332.0+22.4%
IXYS Corp.SYXI12/15/04$10.15$10.332.0+1.8%
Rofin-Sinar Tech Inc.RSTI12/13/04$38.28$42.242.3+10.3%
Average1.0+4.3%

* Net buy prices shown are the total net purchase cost after commissions for all managed accounts divided by the total number of shares.

** Current prices are at least 20 minutes old.

  Subscription Information

Welcome to The Deen's ListTM, an e-mail stock newsletter from Deen Capital Management, Inc.

My intention is to inform you as quickly as is practical regarding my stock market moves. When I buy or sell a stock, first I take care of client accounts, then I buy/sell for my personal account(s), and then, third, I send out this newsletter.

Your feedback is welcome. Send e-mail to deenslist@deencapital.com. To subscribe or unsubscribe, include the word "subscribe" or "unsubscribe" in the Subject line.

This newsletter is free to managed account clients. For a limited time, it is also free to all interested parties.

  Privacy Policy

Your personal information, including your e-mail address, will be held in strict confidence by Deen Capital Management, Inc. We will not share it with or sell it to others.

  Disclaimers

All stocks discussed in The Deen's ListTM involve a high degree of risk. It should not be assumed that any stock discussed in The Deen's ListTM or purchased by Deen Capital Management, Inc. will be profitable.

Past performance is not necessarily indicative of future results.

The information contained herein has been compiled from sources deemed to be reliable; however, we are not responsible for its accuracy or completeness.

 

Ken Deen
Deen Capital Management, Inc.
PO Box 30925
Santa Barbara, CA 93130
(805) 682-1870
deenslist@deencapital.com

Copyright © 2004 Deen Capital Management, Inc.